Transgene SA / Fundamentals
Income statement
- Net revenue
€3.27M - Cost of goods sold
€26.12M - Gross profit
-€22.95M - SG&A expenses
€15.24M - R&D expenses
€67.49M - EBITDA
-€72.49M - D&A
€3.27M - EBIT
-€78.19M - Interest expenses
€2.60M - EBT
-€70.10M - Tax expenses
-€10.41M - Net income
-€59.69M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€10.87M - Changes in working capital
€8.41M - Operating cash flow
-€59.04M - Capex
€4.61M - Other investing cash flow
€18.50M - Net investing cash flow
€12.87M - Total cash dividends paid
€0.00 - Issuance of common stock
-€158.00K - Debt repayment
€0.00 - Other financing cash flow
€72.86M - Net financing cash flow
€59.82M - Foreign exchange effects
-€1.00M - Net change in cash
€11.70M - Cash at end of period
€16.77M - Free cash flow
-€54.43M
Balance sheet
- Cash and cash equivalents
€16.77M - Cash and short-term investments
€16.77M - Total receivables
€1.89M - Inventory
€0.00 - Other current assets
€3.05M - Total current assets
€21.71M - Property, plant & equipment
€13.85M - Goodwill
€0.00 - Intangible assets
€55.00K - Long-term investments
€954.00K - Other non-current assets
€4.41M - Total non-current assets
€19.28M - Total assets
€40.99M - Accounts payable
€6.67M - Short-term debt
€28.81M - Other current liabilities
€4.24M - Total current liabilities
€40.17M - Long-term debt
€1.76M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€2.67M - Total non-current liabilities
€4.43M - Total liabilities
€44.59M - Common stock
€39.82M - Retained earnings
-€58.28M - Other equity
€14.00K - Total equity
-€3.60M - Total liabilities and shareholders' equity
€40.99M
Company information
- Market capitalization
€89.72M - Employees
144 - Enterprise Value
€113.42M
Company ratios
- Gross margin
-
-702.2% Much worse than peer group: 140.0% - EBITDA margin
-
-2,218.1% Much worse than peer group: -2,024.3% - EBIT margin
-
-2,392.5% Much worse than peer group: -2,065.0% - EBT margin
-
-2,145.1% Much worse than peer group: -2,103.5% - Net margin
-
-1,826.6% Much better than peer group: -2,024.9% - ROE
-
1,656.3% Much better than peer group: 156.3% - ROA
-
-145.6% Much worse than peer group: -65.8% - Asset turnover
-
8.0% Worse than peer group: 21.7% - FCF margin
-
-1,947.6% Much worse than peer group: -1,608.3% - FCF yield
-70.9% - Efficiency ratio
2,318.1% - Net sales per employee
-
€22.69K - Net income per employee
-
-€414.53K